-
Event
17 - 18 February 2026, Cardo Brussels (& online)
Newly Implementable Programmes for Prostate, Lung and Gastric Cancer Screening
Three years ago, the European Union reshaped the agenda on cancer screening. The goal? Save lives through early detection, with a focus on prostate, lung, and gastric cancer.
How? Launch a series of projects – PRAISE-U, SOLACE, and TOGAS – to pilot and prepare for the implementation of new screening programmes which account for the needs of individuals and their different backgrounds. Now it's time to assess the progress and turn pilots into programmes.
This is a unique event for the cancer community. Make sure to be part of it.
17 & 18 February - Brussels & online
Registrations are open now!
Read more
-
Event
10 December 2025, Online
Joint Stakeholder Forum of the ALTHEA and DESIPOC projects
More than 40% of cancer patients report their mental health is deteriorating; yet only 19% receive psychiatric or psychological support.
Quality cancer care can only be achieved through a holistic approach that addresses the psychosocial well-being and quality of life of patients.
EU-funded initiatives such as ALTHEA and DESIPOC are already tackling this issue with new technologies to better diagnose and monitor cancer patients.
Join this end-of-the-year stakeholder forum to hear about these projects, exchange with cross-sector experts and patient representatives, and discuss how technology can bridge the gap between mental health needs and available care.
The online event, hosted by the European Cancer Organisation (ECO), takes place on Wednesday 10 December from 15:00 to 17:00 CET. Registrations are open now!
Read more
-
news
20 November 2025
Brussels, 20 November – Each year brings with it 58,000 new cases of cervical cancer in Europe and 27,000 deaths from the disease – all the result of the human papillomavirus (HPV).
It does not have to be this way.
Read more
-
Publication
November 2025
An estimated 31% of men and 25% of women in the EU will receive a cancer diagnosis before the age of 75. Quality screening programmes are essential to improve treatment outcomes and save lives.
Throughout 2024-2025, the European Cancer Organisation (ECO) worked alongside leading cancer experts and partner organisations to assess the current state of cancer screening across Europe.
Read more
-
news
19 November 2025
Major gaps in access, equity and implementation, findings show
Brussels, 18 November – An estimated 31% of men and 25% of women in the EU will receive a cancer diagnosis by age 75. Technological advances in cancer screening approaches offer new opportunities for early detection, but a new analysis shows that too many Europeans are not benefiting from well organised and accessible screening programmes.
Read more
-
Publication
November 2025
A new report from the European Cancer Organisation (ECO) and its HPV and Hep B Action Network highlights persistent inequalities in cervical cancer screening and HPV testing across Europe. It calls for stronger implementation of EU recommendations, greater coordination among European countries, and more cohesion in vaccination and screening programmes.
Read more
-
news
18 November 2025
Opportunities and Challenges
18 November, Brussels – Artificial intelligence (AI) is rapidly transforming virtually every aspect of cancer care – from prevention and diagnosis to treatment and survivorship. Europe can become a global leader in AI and cancer if the technology is properly harnessed. But a Wild West scenario must be avoided.
Read more
-
Publication
November 2025
Opportunities, Challenges, and Policy Recommendations
Artificial intelligence (AI) is rapidly transforming virtually every aspect of cancer care – from prevention and diagnosis to treatment and survivorship. Europe can become a global leader in AI and cancer if the technology is properly harnessed. But a Wild West scenario must be avoided.
Read more
-
Publication
November 2025
Prostate cancer is the most common cancer among European men, with more than 330,000 new cases and 76,000 deaths reported each year. While we continue searching for ways to prevent this disease, detecting it early becomes vitally important. The earlier the diagnosis, the better the outcome.
Read more
